arginine has been researched along with cardiovascular agents in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (14.89) | 18.2507 |
| 2000's | 22 (46.81) | 29.6817 |
| 2010's | 18 (38.30) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, M; Matsumoto, T; Toda, N | 1 |
| Babbedge, RC; Gaffen, Z; Hart, SL; Moore, PK; Wallace, P | 1 |
| Antunes, E; de Nucci, G; Grassi-Kassisse, DM; Withrington, PG | 1 |
| Choate, JK; Paterson, DJ; Sears, CE | 1 |
| Gay, WA; Harris, KM; Lee, R; Nitta, T; Schmid, RA; Schuessler, RB | 1 |
| Jan, CR; Lo, WC; Tseng, CJ; Wu, SN | 1 |
| Capurro, D; Huidobro-Toro, JP | 1 |
| Buralli, S; Gennazzani, A; Ghiadoni, L; Lombardo, M; Petraglia, F; Pinto, S; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Gordan, L; Gorman, R; Kitchens, C; Zumberg, M | 1 |
| Asherova, L; Chagan, L; Cheng, JW; Ioselovich, A | 1 |
| Kawata, K; Matsuda, K; Negishi, M; Sekiguchi, F; Shimamur, K; Shinomiya, K; Sunano, S; Yamamoto, K | 1 |
| Cooke, JP; Weis, M | 1 |
| Toda, N | 1 |
| Ikomi, F; Kousai, A; Mizuno, R; Ohhashi, T | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Ingle, L; Lalukota, K | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Bae, SW; Choi, BY; Choi, YH; Lee, SH; Lee, YS; Pachinger, O; Park, HK; Park, JE; Stühlinger, MC; Yoo, HS; Yu, KH | 1 |
| Barsness, GW; Yang, EH | 1 |
| Antoniades, C; Siasos, G; Stefanadi, E; Stefanadis, C; Tousoulis, D | 1 |
| Ambrose, J; Bernaski, E; Coppola, J; El-Khally, Z; Kurian, D; Mandadi, V; Morlote, M; Pinassi, E; Staniloae, C | 1 |
| Barnard, K | 1 |
| Hu, CP; Huang, H; Jia, SJ; Jiang, DJ; Jiang, JL; Li, YJ; Tan, B | 1 |
| Ahanchi, SS; Kibbe, MR; Tsihlis, ND | 1 |
| Basta, A; Dembinska-Kiec, A; Grzyb, A; Kiec-Wilk, B; Lauterbach, R; Olszanecki, R; Rytlewski, K | 1 |
| Berkowitz, DE; Christianson, DW; Nyhan, D; Santhanam, L | 1 |
| Böhm, F; Channon, KM; Malmström, RE; Pernow, J; Settergren, M | 1 |
| Mangoni, AA; Wadham, C | 1 |
| Coppola, JT; Deshmukh, SH; Hermance, EV; Infantino, MN; Mindrescu, C; Patel, SR; Pinassi, E; Staniloae, CS | 1 |
| Luo, XP; Shi, HM; Sun, T; Tang, YL; Zhou, WB | 1 |
| Ceballos-Reyes, G; Chamorro-Cevallos, G; Hernández-Navarro, MD; Mora-Escobedo, R; Ortiz-Moreno, A; Piñeiro, V | 1 |
| André, C; Bagnost, T; Berthelot, A; da Silva, RF; Demougeot, C; Guillaume, Y; Houdayer, C; Ma, L; Rezakhaniha, R; Stergiopulos, N | 1 |
| Chen, WM; Deng, J; Huang, XN; Wang, YW; Wu, Q | 1 |
| Chen, M; Huo, Y; Li, J; Lou, L; Pan, C; Singh, G; Wang, S; Wu, A; Zhang, D; Zhao, M | 1 |
| Clement, B; Klein, N; Kotthaus, J; Schade, D | 1 |
| Bucciarelli, T; D'Orazio, N; Felaco, M; Franceschelli, S; Gaeta, R; Grilli, A; Riccioni, G; Speranza, L | 1 |
| Cai, W; Ma, G; Sha, X; Shi, X; Zheng, Y; Zhu, Q; Zhu, Y | 1 |
| Förstermann, U; Sessa, WC | 1 |
| Caplin, B; Leiper, J | 1 |
| Khan, AU; Murugan, DD; Mustafa, MR | 1 |
| Jung, C; Pernow, J | 1 |
| Borzak, S; DeMets, D; Hennekens, CH; Hetzel, S; Schneider, R; Schneider, W; Schröder, H; Serebruany, V | 1 |
| Okuda, S; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
| Kaye, DM; Nanayakkara, S; Rajapakse, NW | 1 |
| He, GW; Liu, Z; Lun, LM; Ning, CP; Wang, HW; Wang, J; Xuan, C; Zhang, BB; Zhao, JX | 1 |
| Azhar, G; Deutz, NE; Kim, IY; Schrader, A; Schutzler, SE; Spencer, HJ; Wolfe, RR | 1 |
| Checa, A; Kövamees, O; Lundberg, JO; Östenson, CG; Pernow, J; Shemyakin, A; Wheelock, CE | 1 |
| Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ | 1 |
15 review(s) available for arginine and cardiovascular agents
| Article | Year |
|---|---|
Use of alternative pharmacotherapy in management of cardiovascular diseases.
Topics: Antioxidants; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Coenzymes; Complementary Therapies; Dietary Supplements; Drug Interactions; Education, Pharmacy, Continuing; Fish Oils; Garlic; Humans; Plant Preparations; Soybean Proteins; Sterols; Ubiquinone | 2002 |
Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
Topics: Animals; Arginine; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Humans; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Postoperative Complications; Rabbits; Transplantation, Homologous; Vasodilation; Vasomotor System | 2003 |
[Study on constituents of buckwheat].
Topics: alpha-Amylases; Animals; Anticholesteremic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Arginine; Cardiovascular Agents; Fagopyrum; Flavonoids; Food Hypersensitivity; Humans; Nitric Oxide; Phytosterols; Plant Extracts; Plant Proteins; Rutin; Trypsin Inhibitors | 2003 |
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cardiotonic Agents; Cardiovascular Agents; Crataegus; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Homozygote; Humans; Oxygen Consumption; Plant Extracts; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Societies, Medical; Stroke Volume; Survival Analysis; Treatment Failure; Treatment Outcome; United States | 2004 |
Evolving treatment strategies for chronic refractory angina.
Topics: Acetanilides; Angina Pectoris; Arginine; Benzazepines; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Counterpulsation; Electric Stimulation Therapy; Humans; Ivabradine; Myocardial Revascularization; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Spinal Cord | 2006 |
L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Topics: Age Factors; Arginine; Atherosclerosis; Cardiovascular Agents; Diabetes Mellitus; Endothelium, Vascular; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Time Factors; Vasodilation | 2007 |
The role of nitric oxide in the pathophysiology of intimal hyperplasia.
Topics: Administration, Inhalation; Animals; Apoptosis; Arginine; Arteries; Blood Platelets; Cardiovascular Agents; Cell Proliferation; Chemotaxis, Leukocyte; Drug Carriers; Endothelial Cells; Extracellular Matrix; Genetic Therapy; Humans; Hyperplasia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Platelet Adhesiveness; Platelet Aggregation; Tunica Intima | 2007 |
Arginase and vascular aging.
Topics: Aging; Animals; Arginase; Arginine; Cardiovascular Agents; Drug Design; Elasticity; Endothelium, Vascular; Enzyme Inhibitors; Humans; Models, Molecular; Nitric Oxide; Nitric Oxide Synthase; Protein Conformation; Signal Transduction; Structure-Activity Relationship | 2008 |
Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Drug Delivery Systems; Gene Expression Regulation, Enzymologic; Humans; Nitric Oxide | 2009 |
Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Arginine; Cardiovascular Agents; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Nitric oxide synthases: regulation and function.
Topics: Animals; Arginine; Biopterins; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Mice; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2012 |
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Topics: Animals; Arginase; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress | 2013 |
Role of asymmetric dimethylarginine in cardiorenal syndrome.
Topics: Animals; Arginine; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Delivery Systems; Humans; Nitric Oxide Synthase | 2014 |
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.
Topics: Anti-Inflammatory Agents; Arginine; Biological Transport; Cardio-Renal Syndrome; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Diuretics; Endothelium, Vascular; Erythropoietin; Heart; Hemodynamics; Humans; Inflammation Mediators; Kidney; Nitric Oxide; Oxidative Stress; Sympathetic Nervous System | 2015 |
6 trial(s) available for arginine and cardiovascular agents
| Article | Year |
|---|---|
Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease.
Topics: Adult; Aged; Arginine; Blood Sedimentation; Brachial Artery; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Fibrinogen; Humans; Lipids; Male; Middle Aged; Pioglitazone; PPAR gamma; Prospective Studies; Thiazolidinediones | 2007 |
Effects of oral L-arginine on the pulsatility indices of umbilical artery and middle cerebral artery in preterm labor.
Topics: Administration, Oral; Adult; Arginine; Blood Flow Velocity; Cardiovascular Agents; Female; Humans; Middle Cerebral Artery; Nitric Oxide; Obstetric Labor, Premature; Placental Circulation; Pregnancy; Pregnancy Outcome; Umbilical Arteries | 2008 |
L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.
Topics: Aged; Arginine; Biopterins; Blood Flow Velocity; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Regional Blood Flow; Reperfusion Injury; Treatment Outcome; Vasodilation; Vasodilator Agents | 2009 |
Ranolazine improves endothelial function in patients with stable coronary artery disease.
Topics: Acetanilides; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hyperemia; Inflammation Mediators; Male; Manometry; Middle Aged; Piperazines; Ranolazine; Time Factors; Treatment Outcome; Vasodilation | 2009 |
Aspirin increases nitric oxide formation in chronic stable coronary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Biomarkers; Cardiovascular Agents; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Heme Oxygenase-1; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Up-Regulation | 2013 |
Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
Topics: Acetylcholine; Aged; Arginase; Arginine; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; Nitroprusside; Ornithine; Peripheral Vascular Diseases; Severity of Illness Index; Vascular Resistance; Vasodilation; Vasodilator Agents | 2016 |
26 other study(ies) available for arginine and cardiovascular agents
| Article | Year |
|---|---|
Mechanisms of endothelium-dependent responses to vasoactive agents in isolated porcine coronary arteries.
Topics: Acetylcholine; Animals; Arginine; Calcimycin; Cardiovascular Agents; Coronary Vessels; Endothelium, Vascular; Female; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Norepinephrine; Oxyhemoglobins; Serotonin; Substance P; Swine | 1993 |
Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects.
Topics: Amino Acid Oxidoreductases; Analgesics; Animals; Arginine; Blood Pressure; Cardiovascular Agents; Cerebellum; Enzyme Inhibitors; Formaldehyde; In Vitro Techniques; Indazoles; Male; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Pain Measurement; Rabbits; Rats | 1993 |
Involvement of nitric oxide in the smooth muscle tone of the isolated canine spleen and the responses to acetylcholine and substance P.
Topics: Acetylcholine; Analysis of Variance; Animals; Arginine; Cardiovascular Agents; Cyclooxygenase Inhibitors; Dogs; Female; Indomethacin; Male; Methylene Blue; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Spleen; Substance P; Vasodilation | 1996 |
Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Arginine; Calcium Channel Blockers; Cardiovascular Agents; Cesium; Electric Stimulation; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Heart Rate; Male; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pyrimidines; Vagus Nerve | 1998 |
Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
Topics: Anesthetics, Local; Animals; Arginine; Cardiovascular Agents; Coloring Agents; Coronary Vessels; Echocardiography; Heart Ventricles; Image Processing, Computer-Assisted; Infusions, Intravenous; Lidocaine; Lissamine Green Dyes; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Random Allocation; Sodium Chloride; Swine; Tetrazolium Salts; Ventricular Function, Left | 1998 |
Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats.
Topics: Adenosine; Animals; Arginine; Blood Pressure; Cardiovascular Agents; Enzyme Inhibitors; Heart Rate; Male; Microinjections; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solitary Nucleus; Xanthines | 1998 |
The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Cats; Dose-Response Relationship, Drug; Ligation; Neuropeptide Y; Receptors, Neuropeptide Y | 1999 |
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Topics: Acetylcholine; Adult; Arginine; Ascorbic Acid; Blood Pressure; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Estrogen Replacement Therapy; Estrogens; Female; Forearm; Humans; Indomethacin; Leiomyoma; Middle Aged; omega-N-Methylarginine; Ovariectomy; Postoperative Period; Reference Values; Regional Blood Flow; Uterine Neoplasms; Vasodilation; Vasodilator Agents | 2000 |
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin | 2001 |
Endothelium-dependent relaxation in pulmonary arteries of L-NAME-treated Wistar and stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arginine; Blood Pressure; Body Weight; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Genetic Predisposition to Disease; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Pulmonary Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Stroke; Vasodilation | 2002 |
ATP inhibits pump activity of lymph vessels via adenosine A1 receptor-mediated involvement of NO- and ATP-sensitive K+ channels.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Arginine; Cardiovascular Agents; Endothelium; Enzyme Inhibitors; Glyburide; Indomethacin; Lymphatic System; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Wistar; Receptor, Adenosine A1; Suramin; Xanthines | 2004 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Topics: Adult; Aged; alpha-Tocopherol; Angina, Unstable; Angioplasty, Balloon, Coronary; Arginine; C-Reactive Protein; Cardiovascular Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Insulin; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Statistics as Topic; Treatment Outcome; Triglycerides | 2005 |
Flavanols, cocoa, and cardiology.
Topics: Arginine; Cacao; Cardiovascular Agents; Cardiovascular Diseases; Cerebral Cortex; Endothelium, Vascular; Flavonoids; Humans; Nitric Oxide; Platelet Adhesiveness; Regional Blood Flow | 2006 |
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Topics: Acetylcholine; Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Taurine; Time Factors; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents; Vitamin E | 2007 |
Effect of L-arginine oral supplementation on response to myocardial infarction in hypercholesterolemic and hypertensive rats.
Topics: Administration, Oral; Animals; Arginine; Blood Pressure; Cardiovascular Agents; Dietary Supplements; Hypercholesterolemia; Hypertension; Male; Myocardial Infarction; Myocardium; Nitric Oxide; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2010 |
Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.
Topics: Animals; Aorta; Arginase; Arginine; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Collagen; Compliance; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Heart Diseases; Hypertension; Male; Membrane Proteins; Mesenteric Arteries; Myocardium; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2010 |
Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
Topics: Abdomen; Animals; Aortic Coarctation; Arginine; Atrial Natriuretic Factor; Cardiovascular Agents; Disease Models, Animal; Endothelium; Ginsenosides; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Panax; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Topics: Abietanes; Amino Acid Transport Systems, Basic; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Arginine; Benzofurans; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Cells, Cultured; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelial Cells; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Time Factors; Vasodilation | 2011 |
Prodrug design for the potent cardiovascular agent Nω-hydroxy-L-arginine (NOHA): synthetic approaches and physicochemical characterization.
Topics: Arginine; Cardiovascular Agents; Chemistry, Physical; Drug Design; Hydrogen-Ion Concentration; Molecular Structure; Prodrugs; Stereoisomerism | 2011 |
The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
Topics: Acute Disease; Aged; Amidohydrolases; Arginine; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Chromatography, High Pressure Liquid; Echocardiography, Doppler; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2011 |
Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats.
Topics: Animals; Arginine; Calibration; Cardiovascular Agents; Chromatography, High Pressure Liquid; Gallic Acid; Leonurus; Limit of Detection; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2012 |
Hypotensive effect of Gentiana floribunda is mediated through Ca++ antagonism pathway.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arginine; Atropine; Blood Pressure; Calcium; Cardiovascular Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Gentiana; Hypertension; Indomethacin; Male; Phenylephrine; Phytotherapy; Plant Extracts; Potassium; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstriction; Vasodilator Agents; Verapamil | 2012 |
L-citrulline for protection of endothelial function from ADMA-induced injury in porcine coronary artery.
Topics: Animals; Arginine; Cardiovascular Agents; Citrulline; Coronary Vessels; Cyclic GMP; Drug Evaluation, Preclinical; Endothelium, Vascular; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; Superoxides; Sus scrofa; Vascular System Injuries | 2015 |
Acute ingestion of citrulline stimulates nitric oxide synthesis but does not increase blood flow in healthy young and older adults with heart failure.
Topics: Adult; Aged; Arginine; Cardiovascular Agents; Citrulline; Dietary Supplements; Elder Nutritional Physiological Phenomena; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Hyperemia; Kinetics; Male; Middle Aged; Nitric Oxide; Regional Blood Flow; Severity of Illness Index; Up-Regulation; Young Adult | 2015 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Cystatin C; Disease Models, Animal; Hypertension; Male; Myocardium; NADPH Oxidase 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Troponin I; Wnt Signaling Pathway | 2017 |